Dorsey Wright & Associates’s Braskem BAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-382,829
Closed -$10.8M 119
2018
Q1
$10.8M Buy
382,829
+101,203
+36% +$2.95M 1.66% 16
2017
Q4
$7.4M Buy
281,626
+75,013
+36% +$2.14M 1.34% 25
2017
Q3
$5.76M Buy
206,613
+64,443
+45% +$1.58M 1.33% 13
2017
Q2
$2.95M Buy
142,170
+47,978
+51% +$990K 0.91% 43
2017
Q1
$1.92M Buy
94,192
+27,076
+40% +$570K 0.66% 56
2016
Q4
$1.42M Buy
+67,116
New +$1.19M 0.6% 60
2016
Q3
Sell
-24,252
Closed -$287K 111
2016
Q2
$287K Buy
+24,252
New +$302K 0.15% 106

Other funds holding BAK

Dorsey Wright & Associates's BAK Position: Q2 2018 in Review

Dorsey Wright & Associates sold out of Braskem (BAK) in Q2 2018, closing a stake of 382,829 shares — an estimated $10.8M sold.

Dorsey Wright & Associates first reported a position in BAK in Q2 2016 and held it in 7 quarters. The position peaked at $10.8M in Q1 2018. 98 funds tracked by Wall St. Rank hold BAK as of Q2 2018.

  • Dorsey Wright & Associates reported no remaining Braskem position as of Q2 2018 after selling out during the quarter.
  • Dorsey Wright & Associates sold 382,829 Braskem shares in Q2 2018, an estimated $10.8M.
  • Dorsey Wright & Associates first reported a position in Braskem in Q2 2016 and held it in 7 quarters.
  • Dorsey Wright & Associates's Braskem position peaked at $10.8M in Q1 2018.
  • 98 funds tracked by Wall St. Rank held Braskem as of Q2 2018.

Based on Dorsey Wright & Associates's 13F filing for Q2 2018, filed 6 Jul 2018.